Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...

The first-line therapy for arrhythmogenic right ventricular cardiomyopathy (ARVC) is considered to be β-blockers, which are generally well tolerated. However, findings from the Multidisciplinary Study ...

The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

BOSTON — Radiofrequency (RF) ablation as first-line therapy for paroxysmal atrial fibrillation (AF) was no more effective than antiarrhythmic therapy in a two-year trial conducted in Scandinavia [1].

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.

“Currently, contemporary guidelines recommend a trial of antiarrhythmic drugs prior to considering catheter ablation,” Jason G. Andrade, MD, director of the Atrial Fibrillation Clinic, ...

High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs. A new study in The American Journal ...

The New England Journal of Medicine ©2020. A recent report published in the New England Journal of Medicine describes the case of a patient with persistent skin discoloration associated with the use ...

Although melatonin does improve the outcomes of induced heart attacks in rats, those improvements are not the result of its antioxidant effect, new research finds. Although melatonin does improve the ...